HID-HSCT Versus IST as First-line Treatment for SAA
Clinical trial NCT07338422 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07338422
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-14
- Primary completion
- 2030-09-14
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.